Autoantibodies against type I IFNs in patients with life-threatening COVID-19
2020 · Science · 2,815 citations
https://doi.org/10.1126/science.abd4585
Q
Qian Zhang
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
625
Papers
22.7K
Citations
67
h-index
235
i10-index
Qian Zhang is an academic researcher from BGI Group (China). The author has contributed to research in topics: SARS-CoV-2 and COVID-19 Research & Immunodeficiency and Autoimmune Disorders & COVID-19 Clinical Research Studies. The author has an h-index of 67, co-authored 532 publications.
ORCID: 0000-0002-9040-3289Papers by this author
worksInborn errors of type I IFN immunity in patients with life-threatening COVID-19
2020 · Science · 2,377 citations
https://doi.org/10.1126/science.abd4570
30 Years of NF-κB: A Blossoming of Relevance to Human Pathobiology
2017 · Cell · 1,983 citations
https://doi.org/10.1016/j.cell.2016.12.012
Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths
2021 · Science Immunology · 617 citations
https://doi.org/10.1126/sciimmunol.abl4340
X-linked recessive TLR7 deficiency in ~1% of men under 60 years old with life-threatening COVID-19
2021 · Science Immunology · 415 citations
https://doi.org/10.1126/sciimmunol.abl4348
The RAPIDD ebola forecasting challenge: Synthesis and lessons learnt
2017 · Epidemics · 260 citations
https://doi.org/10.1016/j.epidem.2017.08.002
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat